The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
In a short-term perspective, the company has interesting fundamentals.
UnitedHealth Group accounts for 5.78 % of our USA Portfolio. A trade is currently open since 11/02/2015 with a purchase price of $ 119.36. Discover the other 19 stocks of the USA portfolio managed by the 4-traders portfolio management team.
There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Historically, the company has been releasing figures that are above expectations.
Over the last seven days, analysts have been revising upwards their EPS estimates for the company.
For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
Analysts covering this company mostly recommend stock overweighting or purchase.
Within the weekly time frame the stock shows a bullish technical configuration above the support level at 220.96 USD
Stock prices approach a strong long-term resistance in weekly data at USD 258.7.
The stock is currently in contact with a medium-term resistance that must be gotten rid of so as to resume the upward trend.